Neurogene
NGNE
86 hedge funds and large institutions have $581M invested in Neurogene in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 2 closing their positions.
1,000% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 2
30% more funds holding
Funds holding: 66 → 86 (+20)
20% more capital invested
Capital invested by funds: $483M → $581M (+$98.4M)
4.4% more ownership
Funds ownership: 102.2% → 106.6% (+4.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 23
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.6M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$3.22M |
| 3 |
Jennison Associates
New York
|
+$3.05M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.56M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$2.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$11.7M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$4.86M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.65M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$1.91M |
| 5 |
Walleye Capital
New York
|
-$1.86M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
US Bancorp
Minneapolis,
Minnesota
| $4.7K | -$504 | -13 | -10% |
|
|
FFA
77
Farther Finance Advisors
San Francisco,
California
| $2.1K | – | – | – |
|
|
TC
78
Truvestments Capital
Sarasota,
Florida
| $1.93K | +$1.78K | +46 | New |
|
79
Comerica Bank
Dallas,
Texas
| $1.68K | +$1.55K | +40 | New |
|
80
Osaic Holdings
Scottsdale,
Arizona
| $1.26K | – | – | – |
|
81
Nisa Investment Advisors
St. Louis,
Missouri
| $1.09K | +$1.01K | +26 | New |
|
|
S
82
SignatureFD
Atlanta,
Georgia
| $923 | +$853 | +22 | New |
|
|
SCM
83
Sterling Capital Management
Charlotte,
North Carolina
| $923 | +$853 | +22 | New |
|
|
SAM
84
Smartleaf Asset Management
Boston,
Massachusetts
| $403 | +$388 | +10 | New |
|
85
National Bank of Canada
Montreal,
Quebec, Canada
| $378 | +$39 | +1 | +13% |
|
86
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$187K | -5,135 | Closed |
|
|
HNB
87
Huntington National Bank
Columbus,
Ohio
| – | -$364 | -10 | Closed |
|
88
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$155 | +4 | New |
|
NGNE Hedge Fund Activity: Q3 2024 in Review
86 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q3 2024, worth a combined $581M — up 20% from $483M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new NGNE positions and 2 closed out — a net gain of 20 holders — while 22 added to existing stakes and 23 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $25.6M. The largest seller was Avidity Partners Management, cutting an estimated $11.7M.
- 86 institutional investors held Neurogene (NGNE) as of Q3 2024, up from 66 in Q2 2024.
- Funds reported $581M of Neurogene stock for Q3 2024, up 20% quarter-over-quarter.
- 22 funds opened new Neurogene positions in Q3 2024 and 2 closed out, a net change of +20 holders.
- The largest Neurogene buyer in Q3 2024 was Fidelity Investments, an estimated $25.6M added.
- The largest Neurogene seller in Q3 2024 was Avidity Partners Management, an estimated $11.7M sold.
Based on aggregated 13F filings for Q3 2024.